Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial, becoming the second developer to report results that far exceeded expectations after Pfizer and its partner BioNTech.
The G20 countries have vowed to make efforts to ensure universal access to COVID-19 vaccines, therapeutics and diagnostics, a final statement adopted on Sunday after a two-day G20 summit said.
Jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences, the vaccine was issued a clinical research permit from the National Medical Products Administration on June 19.
Global trials are expected to begin in Uzbekistan late this month, followed by trials in Indonesia, Pakistan and Ecuador.
Queen, Prince Philip celebrate 73rd wedding anniversary amid England's lockdown
The card was first revealed in a photo shared by the Royal Family social media accounts on Thursday. Their great grandchildren, meanwhile, are isolating at Anmer Hall in Norfolk with their parents.
The Sinopharm vaccine requires two doses per individual for efficacy.
With several more phase 3 studies for potential vaccines expected to start over the next six months, researchers are highlighting the need for volunteers from across the United Kingdom to continue to join the fight against coronavirus by taking part in clinical studies by informed choice.
Volunteers, aged between 18 and 59 from Beijing, Chongqing and Hunan provinces, received the vaccine to determine whether it is safe for use on humans, state-run Xinhua news agency reported.
Volunteers from a variety of age groups and backgrounds, including some of the thousands who have registered to be contacted about vaccine studies through the NHS COVID-19 Vaccine Research Registry, have begun taking part in the latest study at 17 National Institute for Health Research (NIHR) sites across the United Kingdom, including MFT.
Coronavirus continues to ravage the world, with the total number of infected people standing at 57,011978 while deaths at 1,362,424, according to John Hopkins University.